CLEVELAND, Aug. 01, 2017 -- Huneo, a biomedical data analytics company, announces the general availability of its SnoreCoach device. SnoreCoach was initially previewed in 2016 in a successfully funded $200,000 kickstarter campaign where several hundred pre-production units were shipped to 29 countries around the world. Huneo has finalized manufacturing and supply chain details and the SnoreCoach is now available for purchase by the public.
SnoreCoach is a sleep position coaching device that works hand-in-hand with Huneo’s SnoreTrack app. SnoreTrack runs on Apple iOS and Android and employs algorithms to filter snoring sounds from other noise; tracks and records each individual snore; and further analyzes snore sounds for patterns often associated with Obstructive Sleep Apnea (OSA). SnoreTrack then generates user-friendly reports and trends on sleep quality and snoring. SnoreCoach is used in conjunction with SnoreTrack to track sleep position and provide a gentle buzz if the user is both snoring and sleeping on his or her back.
“Many of our early adopters and beta users are positional snorers, and SnoreCoach has reduced their snoring time significantly (from 22% to 4% of the total sleep time),” said Alex Zheng, CTO of Huneo.
SnoreTrack was conceptualized while Huneo was capturing and analyzing tens of thousands of in-lab overnight sleep studies. Specific sounds were found to be highly correlated with snoring and OSA. Huneo worked extensively over many years with sleep medicine specialists, including Jed Black, M.D. at Stanford University’s Center for Sleep Science and Medicine, to refine the comprehensive algorithms that drive the SnoreTrack and SnoreCoach systems.
“SnoreTrack and SnoreCoach are unique in that they provide both detailed information about sleep, as well as a non-intrusive solution to improve sleep quality,” said Phil Ryder, CEO of Huneo. “SnoreCoach can effectively take place of a sleep partner’s nudge, causing the snorer to turn over, stop snoring, and sleep more soundly.”
SnoreCoach is now available worldwide at www.SnoreCoach.com for $98.00. The SnoreTrack app is available free of charge in the iOS and Google Play App Store.
About Huneo
Huneo is a biomedical data analytics company headquartered in Cleveland, Ohio, with key personnel in Silicon Valley. It was founded with the idea of bringing advanced techniques for real-time data capture, telemetry, and historization to the healthcare environment. Huneo’s co-founders Phil Ryder and Alex Zheng have combined 40 years’ experience in developing and commercializing massive real-time and time-series data historian systems. Huneo’s mission is to provide the healthcare Industry with an innovative infrastructure to meet the growing needs for efficient capture, storage, analysis, and dissemination of human-derived time-series information beyond the limitations of dedicated on-site systems. With Huneo’s products, healthcare providers can screen, diagnose, and monitor health parameters in real-time, providing instantaneous access to historical data and creating health trends for both individuals and large groups of people, anywhere in the world. Huneo’s extensive work in the sleep bio-signal space has resulted in a HuNet architechture customized for polysomnographic, ECG and EEG analysis studies. In turn, SnoreCoach and SnoreTrack were developed for consumer applications.
For inquiries:
Matt Ryder
[email protected]
440.669.4482


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 



